News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,793 Results
Type
Article (40489)
Company Profile (290)
Press Release (673013)
Multimedia
Podcasts (61)
Webinars (14)
Section
Business (206703)
Career Advice (2024)
Deals (35778)
Drug Delivery (96)
Drug Development (82226)
Employer Resources (174)
FDA (16308)
Job Trends (15030)
News (349441)
Policy (32823)
Tag
Academia (2564)
Accelerated approval (12)
Adcomms (22)
Allergies (99)
Alliances (50224)
ALS (114)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (155)
Approvals (16318)
Artificial intelligence (318)
Autoimmune disease (29)
Automation (20)
Bankruptcy (361)
Best Places to Work (11738)
BIOSECURE Act (19)
Biosimilars (126)
Biotechnology (204)
Bladder cancer (97)
Brain cancer (35)
Breast cancer (384)
Cancer (2977)
Cardiovascular disease (227)
Career advice (1692)
Career pathing (30)
CAR-T (190)
CDC (32)
Cell therapy (514)
Cervical cancer (23)
Clinical research (67897)
Collaboration (1067)
Company closure (3)
Compensation (716)
Complete response letters (26)
COVID-19 (2645)
CRISPR (59)
C-suite (366)
Cystic fibrosis (115)
Data (3181)
Decentralized trials (2)
Denatured (21)
Depression (67)
Diabetes (349)
Diagnostics (6449)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (146)
Drug pricing (124)
Drug shortages (28)
Duchenne muscular dystrophy (147)
Earnings (88680)
Editorial (43)
Employer branding (22)
Employer resources (150)
Events (116043)
Executive appointments (873)
FDA (18094)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (955)
Gene editing (134)
Generative AI (23)
Gene therapy (395)
GLP-1 (801)
Government (4536)
Grass and pollen (6)
Guidances (220)
Healthcare (18888)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (155)
Immuno-oncology (9)
Indications (42)
Infectious disease (2825)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (69)
Intellectual property (126)
Interviews (316)
IPO (16779)
IRA (46)
Job creations (3684)
Job search strategy (1433)
Kidney cancer (13)
Labor market (55)
Layoffs (505)
Leadership (19)
Legal (7958)
Liver cancer (79)
Longevity (12)
Lung cancer (414)
Lymphoma (218)
Machine learning (12)
Management (58)
Manufacturing (419)
MASH (95)
Medical device (13491)
Medtech (13497)
Mergers & acquisitions (19746)
Metabolic disorders (860)
Multiple sclerosis (102)
NASH (16)
Neurodegenerative disease (135)
Neuropsychiatric disorders (35)
Neuroscience (2209)
NextGen: Class of 2025 (6543)
Non-profit (4503)
Now hiring (50)
Obesity (430)
Opinion (218)
Ovarian cancer (103)
Pain (114)
Pancreatic cancer (128)
Parkinson's disease (190)
Partnered (22)
Patents (321)
Patient recruitment (179)
Peanut (50)
People (58455)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (21173)
Phase II (29955)
Phase III (22184)
Pipeline (1722)
Policy (205)
Postmarket research (2570)
Preclinical (9028)
Press Release (64)
Prostate cancer (144)
Psychedelics (37)
Radiopharmaceuticals (261)
Rare diseases (474)
Real estate (6006)
Recruiting (67)
Regulatory (22941)
Reports (50)
Research institute (2340)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (93)
Series A (158)
Series B (110)
Service/supplier (11)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3636)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (61)
The Weekly (38)
Vaccines (804)
Venture capital (57)
Weight loss (259)
Women's health (47)
Worklife (16)
Date
Today (8)
Last 7 days (518)
Last 30 days (1723)
Last 365 days (31049)
2025 (18067)
2024 (35564)
2023 (40474)
2022 (51634)
2021 (56244)
2020 (54471)
2019 (46898)
2018 (35313)
2017 (32506)
2016 (31949)
2015 (38017)
2014 (31842)
2013 (26766)
2012 (28943)
2011 (29608)
2010 (27666)
Location
Africa (733)
Alabama (68)
Alaska (7)
Arizona (246)
Arkansas (14)
Asia (39228)
Australia (6356)
California (7688)
Canada (2436)
China (706)
Colorado (326)
Connecticut (329)
Delaware (202)
Europe (85071)
Florida (1172)
Georgia (258)
Hawaii (2)
Idaho (60)
Illinois (656)
India (28)
Indiana (371)
Iowa (17)
Japan (239)
Kansas (110)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1061)
Massachusetts (5760)
Michigan (250)
Minnesota (469)
Mississippi (4)
Missouri (95)
Montana (28)
Nebraska (25)
Nevada (85)
New Hampshire (67)
New Jersey (2154)
New Mexico (29)
New York (2150)
North Carolina (1151)
North Dakota (8)
Northern California (3405)
Ohio (242)
Oklahoma (16)
Oregon (35)
Pennsylvania (1668)
Puerto Rico (18)
Rhode Island (37)
South America (1111)
South Carolina (34)
South Dakota (1)
Southern California (2888)
Tennessee (128)
Texas (1176)
United States (28598)
Utah (222)
Virginia (196)
Washington D.C. (73)
Washington State (657)
West Virginia (4)
Wisconsin (67)
713,793 Results for "asklepios biopharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split
May 22, 2025
·
4 min read
Press Releases
1Elevan Biopharmaceuticals, Inc. Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, Indiana
June 18, 2025
·
3 min read
Press Releases
Medicovestor, Inc. and Sanyou Biopharmaceuticals Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
June 10, 2025
·
3 min read
Press Releases
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
July 16, 2025
·
8 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa
July 30, 2025
·
4 min read
Press Releases
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million
July 28, 2025
·
9 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders
June 9, 2025
·
3 min read
Press Releases
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
May 19, 2025
·
6 min read
BioMidwest
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will be hosting a virtual meeting of its stockholders at 1pm ET on Monday, July 8th, 2024.
June 20, 2024
·
5 min read
1 of 71,380
Next
